The Public Health Agency of Canada, Thrombosis Canada and the National Collaborating Centre for Infectious Diseases (NCCID) present a webinar to inform health care providers on the treatment and reporting of Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT).
This webinar is on the mental health challenges at the population level and their behavioural response due to COVID-19.
This moderated, live webinar describes the features and management of delayed injection site reactions following administration of COVID-19 vaccines.
The webinar presentation and Q&A event, for health care and vaccine providers, provides information to support the preparation and operational plans for COVID-19 vaccine immunization clinics.
This COVID-19 vaccines foundational webinar will provide information about the vaccine regulatory authorization from Health Canada, guidance developed by NACI that informs the Canadian Immunization Guide, and information on COVID-19 vaccine technologies.
This moderated webinar is for health care providers who are administering COVID-19 vaccines. It describes allergy-related contraindications or precautions to COVID-19 vaccination and the features and management of anaphylaxis following administration of COVID-19 vaccines.
This webinar discusses some of the specific challenges for vaccine uptake amongst First Nations, Inuit and Métis populations, including their negative historic and contemporary experiences with mainstream healthcare systems, health care professionals, and vaccine providers in Canada.
This webinar provides health care professionals with the latest COVID-19 testing and testing technologies in Canada.
This webinar is to inform health care and vaccine providers on the NACI recommendations on the use of the Moderna COVID-19 vaccine.
This webinar is to inform health care providers on the NACI recommendations on the use of this COVID-19 vaccine.
In the final episode of this series, TB program staff reflect on their lessons from the outbreak, including what worked well, and what is still needed for TB elimination.
Our third episode looks deeper into the impact of stigma, particularly on the experiences of one young woman whose life had been repeatedly up-ended by the disease.